Name: Marlen Ultralite One-Piece Shallow Convex Pre-Cut Opaque Drainable Pouch With Aquatack Barrier,1 (25Mm) Stoma Opening,10/Pack,55122
Brand: MARLEN MANUFACTURING & DEVELOPMENT CO.
SKU: 33082-173452
Price: 89.99 USD
Availability: InStock

Marlen Ultralite One-Piece Shallow Convex Pre-Cut Opaque Drainable Pouch With Aquatack Barrier,1 (25Mm) Stoma Opening,10/Pack,55122 - 33082-173452

By MARLEN MANUFACTURING & DEVELOPMENT CO.

$89.99

(566 Reviews)

Model

33082-173452

Store

Health Products For You

Manufacturer

MARLEN MANUFACTURING & DEVELOPMENT CO.

Detail

Marlen UltraLite One-Piece Shallow Convex Pre-cut Opaque Drainable Pouch is one-piece disposable and drainable system for ileostomies and colostomies. New slim and contoured design has cloth-like comfort cover on body side. It has completely odor-proof material.

Category

Ostomy

BALTIMORE -- More than half of primary care providers are not using time in range in clinical practice, and only one-third of people with diabetes use the metric as part of their glycemic management, according to a presenter. Research from The diaTribe Foundation presented at the Association of Diabetes Care & Educational Specialists Annual Conference revealed that while a large majority of endocrinologists and diabetes care and education specialists use time in range in practice when caring for people with diabetes, HbA1c remains a stronger fixture in diabetes care, particularly ...

>Read More

BALTIMORE -- In this video exclusive, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Sherita Hill Golden, MD, MHS, about historical drivers of health inequities in diabetes and obesity and specific actions providers can take today. Weiner is owner and clinical director of Susan Weiner Nutrition, PLLC, in North Bellmore, NY, an Endocrine Today Editorial Board member and the Diabetes in Real Life column editor. Golden is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism and vice president and chief diversity officer of the office of diversity, inclusion and ...

>Read More

Its a very exciting time in inflammatory skin diseases, Emma Guttman-Yassky, MD, PhD, told Healio. By dividing her time between clinical care, academic research and administrative duties as the Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine, Guttman-Yassky has seen how biologics have transformed treatment. Now we have the drugs to treat patients safely based on the mechanism of action that we didnt have even 10 years ago, said Guttman-Yassky, who also is a member of Healios ...

>Read More

Among extremely low gestational age neonates, gestational age, birthweight z-score and prenatal steroids correlated with an increased risk for chronic kidney disease. The risk factors and natural history for CKD progression in infants and children is poorly understood, Sangeeta R. Hingorani, MD, MPH, an attending physician at Seattle Childrens Hospital and an associate professor of pediatrics at the University of Washington School of Medicine, and colleagues wrote. They added, Questions remain regarding the independent effect of prematurity, low birth weight or ...

>Read More

Abemaciclib resulted in an approximately twofold higher venous thromboembolism rate in a real-world setting compared with clinical trials among patients with metastatic breast cancer, according to study results published in Cancer. Researchers also reported a significantly higher risk for death among patients who developed thrombosis. The potential risk for VTE associated with abemaciclib (Verzenio, Eli Lilly) observed in previous clinical trials may be higher in the real-world setting, given that clinical trials select for certain patients with limited comorbidities, according to study ...

>Read More

Patients who received treatment for high-grade nonmuscle-invasive bladder cancer had similar outcomes irrespective of European Association of Urology risk status, results of a retrospective study showed. Investigators found similar nonresponse rates to induction therapy with bacillus Calmette-Guérin (BCG) among patients with high-grade tumors regardless of being categorized as having high-risk or intermediate-risk nonmuscle-invasive tumors. The findings suggest certain clinical practice guidelines should be updated so that all patients with high-grade nonmuscle-invasive bladder cancer ...

>Read More

For the first time in 3 years, the Women in Medicine Summit will be taking place in person, from Sept. 16 to 17, in Chicago. The 2-day summit offers education, toolkits, skill-building, networking and other opportunities to amplify women in medicine and work toward gender equity in health care. More than 400 health care professionals are expected to attend. Healio spoke with Shikha Jain, MD, FACP, chair and founder of the Women in Medicine Summit, president of the nonprofit Women in Medicine, and the host of Healios Oncology Overdrive podcast, about her goals for this years summit ...

>Read More

Product Details for 33082-173452